Short-term low-dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly effective for the eradication of Helicobacter pylori

European Journal of Gastroenterology and Hepatology

Volumn 9, Issue 1, 1997, Pages 45-48

  Caselli, Michele ^a   Trevisani, Lucio ^b   Tursi, Antonio ^c   Sartori, Sergio ^b   Ruina, Marco ^a   Luzzi, Ida ^d   Gaudenzi, Piergiorgio ^a   Alvisi, Vittorio ^a   Gasbarrini, Giovanni ^b  

^a UNIVERSITY OF FERRARA   (Italy)

^b S ANNA HOSPITAL   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Azithromycin; Helicobacter pylori; Lansoprazole; Metronidazole; OCN triple therapy

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE; NITROIMIDAZOLE DERIVATIVE; OMEPRAZOLE; STOMACH SECRETION INHIBITOR; TOLUIDINE DERIVATIVE; UREASE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COST; DRUG EFFICACY; DRUG TOLERANCE; DUODENUM ULCER; ENDOSCOPIC BIOPSY; FEMALE; GASTRITIS; GRAM NEGATIVE INFECTION; HEALTH CARE COST; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; STOMACH BIOPSY; ULCER HEALING;

EID: 0031024841     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199701000-00012     Document Type: Article

References (19)

1. Goddard A, Logan R: One-week low-dose triple therapy: new standards for Helicobacter pylori treatment. Eur J Gastroenterol Hepatol 1995, 7:1-3.
2. Bazzoli F, Zagari M, Fossi S, Pozzato P, Alam G, Simoni P, et al.: Short-term low-dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994, 6:773-777.
3. Colujczyuski Y, Burette A: Drugs therapy for Helicobacter pylori infection: problems and pitfalls. Am J Gastroenterol 1990, 85:1545-1551.
4. Thijs JC, Van Zwei AA, Oey HB: Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori. Scand J Gastroenterol 1993, 28:934-938.
5. Nair P, McNulty CAM, Dent J: Helicobacter pylori infection and metronidazole resistance in Gloucester. Gut 1995, 37(suppl. 1):A46.
6. Xia HX, Buckley M, Hyde D, Keane CT, O'Morain CA: Effects of antibiotic resistance on clarithromycin-combined triple therapy for Helicobacter pylori. Gut 1995, 37(suppl. 1):A55.
7. Lopez-Brea M, Martinez MJ, Domingo D, Sanchez-Romero I, Sauz JC, Alarcon T: Evolution of resistance to several antibiotics in H. pylori over a 4 year period. Gut 1995, 37(suppl. 1):A97.
8. Caselli M, Trevisani L, Pazzi P, Putinati S, Stabellini G: Campylobacter pylori et muqueuse gastrique. Gastroenterol Clin Biol 1988, 12:586-587.
9. Whitehead R, Truelove SC, Gear MWL: The histological diagnosis of chronic gastritis in fibreoptic gastroscope biopsy specimens. J Clin Pathol 1972, 25:1-11.
10. Caselli M, Ruina M, Fabbri P, Balhous W, Alvisi V: A comparative trial of short-term therapy with omeprazole plus either amoxycillin or azithromycin for Helicobacter pylori eradication. J Antimicrob Chemother 1996, 37:849-850.
11. Tursi A, Cammarota C, Montalto M, Papa A, Fedeli G, Gasbarrini G: The use of azithromycin in a short-term low-dose triple therapies for Helicobacter pylori infection. Am J Gastroenterol 1996, 91:817-818.
12. Al-Assi MT, Genta RM, Kartunen TI, Cole RA, Graham DY: Azithromycin triple therapy for Helicobacter pylori infection: azithromycin, tetracycline and bismuth. Am J Gastroenterol 1993, 90:403-405.
13. Betoni G, Sassatelli R, Nigrisoli E, Tansini P, Bianchi G, Della Casa G, et al.: Triple therapy with azithromycin, omeprazole and amoxicillin is highly effective in the eradication of Helicobacter pylori: a controlled trial versus omeprazole plus amoxicillin. Am J Gastroenterol 1996, 91:258-263.
14. Foulds G, Shepard RM, Johnson RB: The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother 1995, 25(suppl. A):73-82.
15. Harrison JD, Jones JA, Morris DL: Azithromycin levels in plasma and gastric tissue, juice and mucus. Eur J Clin Microbiol Infect Dis 1991, 10:862-864.
16. Hopkins S: Clinical toleration and safety of azithromycin. Am J Med 1991, 91(suppl. 3A):40-45.
17. Gladue RP, Bright GM, Isaacson RE, Newborg MF: In vitro and in vivo uptake of azithromycin (cp-62, 993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob Agents Chemother 1989, 33:277-282.
18. Berry V, Jennings K, Woodnutt G: Bactericidal and morphological effects of amoxycillin on Helicobacter pylori. Antimicrob Agents Chemother 1995, 8:1859-1861.
19. Caselli M, Pedriali R, Ruina M, Gallerani I, Gaudenzi P, Alvisi V: Lansoprazole in gastric juice and H. pylori. Gut 1996, 39(Suppl. 2):A7.